Catalyst Biosciences Inc (CBIO)

Catalyst Biosciences (CBIO) Stock Price & Analysis


CBIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.19 - $0.40
Previous Close$0.23
Average Volume (3M)239.37K
Market Cap
Enterprise Value$963.36K
Total Cash (Recent Filing)$8.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)0.6
Aug 03, 2023
3.1 (1289.34%)
Share Statistics
EPS (TTM)0.42
Shares Outstanding30,782,924
10 Day Avg. Volume211,394
30 Day Avg. Volume239,365
Standard Deviation1.31
Financial Highlights & Ratios
Price to Book (P/B)-0.34
Price to Sales (P/S)74.91
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.03
Enterprise Value/Gross Profit-240.84
Enterprise Value/Ebitda-0.02
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Catalyst Biosciences Inc’s price range in the past 12 months?
Catalyst Biosciences Inc lowest stock price was $0.19 and its highest was $0.40 in the past 12 months.
    What is Catalyst Biosciences Inc’s market cap?
    Currently, no data Available
    When is Catalyst Biosciences Inc’s upcoming earnings report date?
    Catalyst Biosciences Inc’s upcoming earnings report date is Aug 03, 2023 which is in 56 days.
      How were Catalyst Biosciences Inc’s earnings last quarter?
      Catalyst Biosciences Inc released its earnings results on May 04, 2023. The company reported $0.01 earnings per share for the quarter, the consensus estimate of $0.01 by $0.
        Is Catalyst Biosciences Inc overvalued?
        According to Wall Street analysts Catalyst Biosciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Catalyst Biosciences Inc pay dividends?
          Catalyst Biosciences Inc pays a Annually dividend of $0.24 which represents an annual dividend yield of N/A. See more information on Catalyst Biosciences Inc dividends here
            What is Catalyst Biosciences Inc’s EPS estimate?
            Catalyst Biosciences Inc’s EPS estimate is -$0.07.
              How many shares outstanding does Catalyst Biosciences Inc have?
              Catalyst Biosciences Inc has 37,759,827 shares outstanding.
                What happened to Catalyst Biosciences Inc’s price movement after its last earnings report?
                Catalyst Biosciences Inc reported an EPS of $0.01 in its last earnings report, expectations of $0.01. Following the earnings report the stock price went up 4.762%.
                  Which hedge fund is a major shareholder of Catalyst Biosciences Inc?
                  Currently, no hedge funds are holding shares in CBIO


                  Catalyst Biosciences Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Catalyst Biosciences Inc

                  Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding CBIO

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold CBIO. The ETFs are listed according to market value of CBIO within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adamis Pharma
                  Adaptimmune Therapeutics
                  Daré Bioscience
                  vTv Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis